Effect of Aerobic and Resisted Exercise on Lipid Profile and Quality of Life in Overweight Breastfeeding Women

Sponsor
Cairo University (Other)
Overall Status
Completed
CT.gov ID
NCT06098638
Collaborator
(none)
54
1
2
6.9
7.8

Study Details

Study Description

Brief Summary

the aim of the study was to investigate the effect of aerobic and resisted exercise program on lipid profile and quality of life in overweight breastfeeding women.

Condition or Disease Intervention/Treatment Phase
  • Other: Nutritional recommendation and Faradic stimulation program
  • Other: aerobic and resisted exercise for 12 weeks
N/A

Detailed Description

Although previous studies reported that exercise training during the postpartum period could improve the lipid profile and quality of life in overweight women and reduce the postpartum fatigue . None of them had investigated the effect of aerobic and resisted exercises on lipid profile and quality of life in overweight breastfeeding women.this trial will include 2 groups:

Group (A): was consist of 27 overweight breastfeeding women, who received nutritional recommendation and faradic current stimulation for 20 min on abdominal surface 2 times per week for 12 weeks.

Group (B): was consist of 27 overweight breastfeeding women, who received the same nutritional recommendation and faradic current stimulation for 20 min on abdominal surface 2 times per week plus exercise training (aerobic + resisted) for 12 weeks.

Study Design

Study Type:
Interventional
Actual Enrollment :
54 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
parallel assignmentparallel assignment
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
double (participant, outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effect of Aerobic and Resisted Exercise on Lipid Profile and Quality of Life in Overweight Breastfeeding Women: A Randomized Clinical Trial
Actual Study Start Date :
Jan 1, 2023
Actual Primary Completion Date :
Jul 31, 2023
Actual Study Completion Date :
Jul 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: control group

Group (A) included 27 overweight breastfeeding woman who received nutritional recommendation and faradic current stimulation on the abdominal surface for 12 weeks, while group

Other: Nutritional recommendation and Faradic stimulation program
proper maternal nutrition and fluid intake during breast-feeding per day for 12 weeks and2 sessions per week, each session 20 minutes, for 12 weeks. Frequency of 65 Hz, and width pulse 300 ms, with contraction time 10 sec and relaxation time 10 sec

Experimental: exercise group

Group (B) 27 overweight breastfeeding women, who received the same nutritional recommendation and faradic current stimulation on the abdominal surface plus exercise training (aerobic + resisted) for 12 weeks.

Other: Nutritional recommendation and Faradic stimulation program
proper maternal nutrition and fluid intake during breast-feeding per day for 12 weeks and2 sessions per week, each session 20 minutes, for 12 weeks. Frequency of 65 Hz, and width pulse 300 ms, with contraction time 10 sec and relaxation time 10 sec

Other: aerobic and resisted exercise for 12 weeks
Each woman in group (B) participated in a moderate exercise program (aerobic+resistive), 3 days/week, for 12 weeks. The session began with 15 minutes of aerobic exercise on a bicycle ergometer, at 60% of heart rate reserve (HRR), with HRR estimated (220-age-resting heart rate). Then, the participant was performed 15 minutes of resistive exercise (two sets of 8-12 repetitions at 75% of one repetition maximum (1-RM) for basic core exercises in the form of hip lifts, knee extension and flexion, crunches, shoulder flexion and extension, elbow flexion and extension with resistance

Outcome Measures

Primary Outcome Measures

  1. measurement of lipid parameter level of High-density lipoprotein (HDL) mg/dL [12 weeks]

    It was used to measure the lipid profile parameters (High-density lipoprotein (HDL)- level in for each woman in the both groups (A & B) at pre-treatment and post-treatment.

  2. measurement of Low-density lipoprotein (LDL) mg/dL [12 weeks]

    It was used to measure the lipid profile parameters Low-density lipoprotein (LDL) level for each woman in the both groups (A & B) at pre-treatment and post-treatment.

  3. measurement of Triglycerides (TG) mg/dL [12 weeks]

    t was used to measure the lipid profile parameters Triglycerides (TG) level for each woman in the both groups (A & B) at pre-treatment and post-treatment.

Secondary Outcome Measures

  1. calculation of score of Short Form 36 Health Survey Questionnaire (SF-36) (Arabic version): [12 weeks]

    It was assessed using the SF-36 (Arabic version) questionnaire in both groups (A & B) before and after treatment, which consists of 36 questions. Answers were awarded a score in a five-point scale (0-4).Scores for each of the dimensions range from 0 (worst level of functioning) to 4 (best level of functioning)

Other Outcome Measures

  1. body mass index (BMI) kg/m² [12 weeks]

    The height and weight were determined for each woman in the both groups (A & B) to calculate her (BMI = (weight in kg)/(height in m^2 ) ) at pre-treatment and post-treatment

  2. waist to hip ratio (W/H ratio) [12 weeks]

    The waist and hip circumferences were taken for each woman in both groups (A & B) before and after treatment course for calculating waist and hip ratio (W/H ratio) by dividing waist circumference (WC) on the hip circumference (HC).

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 30 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. All of women were sedentary, non-smoking, breastfeeding women at their 3rd to 6th months postpartum

  2. they had delivered a single, healthy, mature fetus with no complications through normal vaginal delivery.

  3. Their age was ranged from 20 to 30 years old.

  4. Their parity number was one or two.

  5. They were overweight (body mass index (BMI) was ranged from 25 to 30 kg/m²).

Exclusion Criteria:
  1. Having chronic disorders, heart disease, respiratory infections, diabetes mellitus, pelvic abnormalities, hormonal abnormalities, psychological problems, menstrual disorders or anemia of other pathological origins.

  2. Receiving any type of physical exercise or sport.

  3. Following a specific diet program.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Marwa Gamal Mohamed Ali Anany Abū Kabīr Abu Kabir Egypt 055

Sponsors and Collaborators

  • Cairo University

Investigators

  • Principal Investigator: marwa G anany, Cairo University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Marwa Gamal Mohamed Ali, physical therapist at Abo Kabir general hospital, Cairo University
ClinicalTrials.gov Identifier:
NCT06098638
Other Study ID Numbers:
  • No:P.T.REC/012/004227
First Posted:
Oct 24, 2023
Last Update Posted:
Oct 24, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Marwa Gamal Mohamed Ali, physical therapist at Abo Kabir general hospital, Cairo University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 24, 2023